Medical alert issued after reports of insulin leakage from insulin pump cartridges
Insulin pumps (pictured) are a common treatment method for people living with diabetes.
The MHRA recommendation to treat people affected said: “Healthcare professionals should inform patients who use the Accu-Chek Insight of the risk of leakage and the updated instructions to reduce risk. Where possible, patients should be moved onto alternative pumps in accordance with the actions in the National Patient Safety Alert.
“A risk assessment must be recorded with all users of Accu-Chek Insight pumps. This should involve a discussion of the risks of continuing treatment with the affected device and consider the best interest of the patient and the management of their diabetes.
“Patients who continue to use the Accu-Chek Insight pump should be instructed to follow the advice in the manufacturer’s latest Field Safety Notice. This includes using the new adapter and tubing. Users should also be instructed to inspect the pump and cartridges regularly for cracks or leaks, and to check blood glucose levels multiple times throughout the day. For the full recommendations to users, see the Field Safety Notice and our press release.
“Roche Diabetes Care ceased marketing the Accu-Chek Insight pump in the UK at the end of 2021 and new patients will not be offered the pump. Therefore, all existing Accu-Chek Insight pump users will need to be transferred to an alternative pump at the end of their pump warranty, irrespective of the outcome of their risk assessment.”
Support DRWF by making a donation here
Find out more about DRWF-funded research here
Find out more about DRWF fundraising here
To receive the charity’s latest bulletins as they become available, please sign up here
Read DRWF diabetes information leaflets here
Join the Diabetes Wellness Network here
I would like to make a regular donation of
I would like to make a single donation of